Prediction of binding characteristics between von Willebrand factor and platelet glycoprotein Ibα with various mutations by molecular dynamic simulation.

[1]  Gerhard Hummer,et al.  Dynamic Histogram Analysis To Determine Free Energies and Rates from Biased Simulations. , 2017, Journal of chemical theory and computation.

[2]  J. Emsley,et al.  Gene of the issue: GP1BA gene mutations associated with bleeding , 2017, Platelets.

[3]  K. Huber,et al.  Antithrombotic therapy for acute coronary syndrome: Past, present and future , 2017, Thrombosis and Haemostasis.

[4]  E. Favaloro,et al.  Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies. , 2017, Methods in molecular biology.

[5]  R. Chuit,et al.  Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation , 2016, Seminars in Thrombosis and Hemostasis.

[6]  James C. Campbell,et al.  Data on the purification and crystallization of the loss-of-function von Willebrand disease variant (p.Gly1324Ser) of the von Willebrand factor A1 domain , 2016, Data in brief.

[7]  P. Onck,et al.  CHARMM TIP3P Water Model Suppresses Peptide Folding by Solvating the Unfolded State. , 2016, The journal of physical chemistry. B.

[8]  Shu Takagi,et al.  Prediction of Molecular Interaction between Platelet Glycoprotein Ibα and von Willebrand Factor using Molecular Dynamics Simulations. , 2016, Journal of atherosclerosis and thrombosis.

[9]  David D. McManus,et al.  MicroRNAs in platelet function and cardiovascular disease , 2015, Nature Reviews Cardiology.

[10]  S. Goto,et al.  Adhesive Forces between A1 Domain of von Willebrand Factor and N-terminus Domain of Glycoprotein Ibα Measured by Atomic Force Microscopy. , 2015, Journal of atherosclerosis and thrombosis.

[11]  S. Takagi,et al.  Platelets: Small in Size But Essential in the Regulation of Vascular Homeostasis - Translation From Basic Science to Clinical Medicine. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[12]  Alexander D. MacKerell,et al.  Conformational sampling of oligosaccharides using Hamiltonian replica exchange with two-dimensional dihedral biasing potentials and the weighted histogram analysis method (WHAM). , 2015, Journal of chemical theory and computation.

[13]  T. Springer,et al.  Structural Basis of Regulation of von Willebrand Factor Binding to Glycoprotein Ib* , 2014, The Journal of Biological Chemistry.

[14]  Jing Huang,et al.  CHARMM36 all‐atom additive protein force field: Validation based on comparison to NMR data , 2013, J. Comput. Chem..

[15]  Jill E. Gready,et al.  Optimization of parameters for molecular dynamics simulation using smooth particle‐mesh Ewald in GROMACS 4.5 , 2011, J. Comput. Chem..

[16]  José A López,et al.  Platelet Glycoprotein Ibβ/IX Mediates Glycoprotein Ibα Localization to Membrane Lipid Domain Critical for von Willebrand Factor Interaction at High Shear* , 2011, The Journal of Biological Chemistry.

[17]  Jongseong Kim,et al.  A mechanically stabilized receptor–ligand flex-bond important in the vasculature , 2010, Nature.

[18]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[19]  Klaus Schulten,et al.  Flow-induced structural transition in the beta-switch region of glycoprotein Ib. , 2008, Biophysical journal.

[20]  H. White,et al.  Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease. , 2004, Blood.

[21]  S. Goto,et al.  Understanding the mechanism and prevention of arterial occlusive thrombus formation by anti-platelet agents. , 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents.

[22]  M. Murata,et al.  Identification of a novel point mutation in platelet glycoprotein Ibα, Gly to Ser at residue 233, in a Japanese family with platelet‐type von Willebrand disease , 2003, Journal of thrombosis and haemostasis : JTH.

[23]  Scott L Diamond,et al.  Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val. , 2003, Blood.

[24]  Zaverio M. Ruggeri,et al.  Platelets in atherothrombosis , 2002, Nature Medicine.

[25]  J. Sixma,et al.  Structures of Glycoprotein Ibα and Its Complex with von Willebrand Factor A1 Domain , 2002, Science.

[26]  B. Chong,et al.  Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations. , 2001, Blood.

[27]  L. McIntire,et al.  Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions. , 2001, Blood.

[28]  R. Liddington,et al.  Mapping the Glycoprotein Ib-binding Site in the von Willebrand Factor A1 Domain* , 2000, The Journal of Biological Chemistry.

[29]  S. Vasudevan,et al.  Modeling and Functional Analysis of the Interaction between von Willebrand Factor A1 Domain and Glycoprotein Ibα* , 2000, The Journal of Biological Chemistry.

[30]  Brian Savage,et al.  Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow , 1998, Cell.

[31]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[32]  S. Goto,et al.  Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. , 1998, The Journal of clinical investigation.

[33]  R. Marchant,et al.  Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. , 1996, Blood.

[34]  J. Ware,et al.  Conformational Changes in the A1 Domain of von Willebrand Factor Modulating the Interaction with Platelet Glycoprotein Ib (*) , 1996, The Journal of Biological Chemistry.

[35]  K. Cooney,et al.  Comparative analysis of type 2b von Willebrand disease mutations: implications for the mechanism of von Willebrand factor binding to platelets. , 1996, Blood.

[36]  Shankar Kumar,et al.  Multidimensional free‐energy calculations using the weighted histogram analysis method , 1995, J. Comput. Chem..

[37]  Y. Ikeda,et al.  Characterization of the Unique Mechanism Mediating the Shear-dependent Binding of Soluble von Willebrand Factor to Platelets (*) , 1995, The Journal of Biological Chemistry.

[38]  T. Matsushita,et al.  Identification of Amino Acid Residues Essential for von Willebrand Factor Binding to Platelet Glycoprotein Ib. , 1995, The Journal of Biological Chemistry.

[39]  J. Ware,et al.  von Willebrand factor. , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  J. Ware,et al.  A Role for von Willebrand Factor Proline Residues 702-704 in Ristocetin-Mediated Binding to Platelet Glycoprotein Ib , 1993, Thrombosis and Haemostasis.

[41]  S. O’Donoghue,et al.  Determination of the solution structure of a platelet-adhesion peptide of von Willebrand factor. , 1992, Biochemistry.

[42]  K. Titani,et al.  Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib. , 1992, Blood.

[43]  J. Moake,et al.  von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. , 1991, The Journal of clinical investigation.

[44]  J. Ware,et al.  Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding. , 1991, The Journal of biological chemistry.

[45]  J. Ware,et al.  Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  V. Vicente,et al.  Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib. , 1988, The Journal of biological chemistry.

[47]  J. Miller,et al.  Unique interactions of asialo von Willebrand factor with platelets in platelet-type von Willebrand disease. , 1987, Blood.

[48]  K. Titani,et al.  The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. , 1986, The Journal of biological chemistry.